[1]
Salajegheh, P. et al. 2025. Daratumumab Versus Control Treatment: A Systematic Review and Meta-analysis Study of Survival Outcomes Among Multiple Myeloma Patients. Galen Medical Journal. 14, (Oct. 2025), e3958. DOI:https://doi.org/10.31661/gmj.v14i.3958.